UK Stocks-Factors to watch on July 10 (updated)
UPDATE 1-UK Stocks-Factors to watch on July 10 Adds new items, updates futures
July 10 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Friday, with futures FFIc1 up 0.3%.
* EASYJET: easyJet EZJ.L said it had agreed in principle to a rival £5.7 billion ($7.65 billion), or £7.15 per-share, takeover approach from Apollo GlobalAPO.N.
* HAYS: Hays HAYS.L said it expects annual operating profit at the top end of market expectations, helped by cost cuts and stronger consultant productivity.
* MJ GLEESON: MJ Gleeson GLEG.L flagged an uncertain outlook for the fiscal year started July 1, citing global geopolitical events and potential policy changes under a new UK government.
* VODAFONE: UAE's telecom operator E& Group EAND.AD said it will sell its entire stake in Vodafone VOD.L for $5.95 billion.
* ASTRAZENECA: A U.S. appeals court upheld a ruling for AstraZeneca AZN.L against allegations that its blockbuster lung-cancer drug Tagrisso infringed patents owned by Pfizer PFE.N subsidiary Wyeth.
* SHOPPING: The number of people visiting British shops fell 3.4% in June from a year earlier as a heatwave kept many indoors, industry data showed.
* OIL: Oil prices fell in early trading but remained on track for weekly gains as the United States and Iran continued trading strikes.
* GOLD: Gold edged lower and was on track for a weekly fall on concerns that escalating U.S.-Iran tensions could fuel inflation and keep the Federal Reserve on a hawkish monetary policy path.
* METALS: Copper advanced, supported by a weak dollar and easing fears around a rash of tit-for-tat strikes between the U.S. and Iran.
* For more on the factors affecting European stocks, please click on: LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB
(Compiled by Megha Kumari in Bengaluru; Editing by Ronojoy Mazumdar)
Recent news on AstraZeneca
See all newsUK Stocks-Factors to watch on July 10 (updated)
UK Stocks-Factors to watch on July 10
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight (updated)
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight
UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains